Europe Archives - Page 66 of 93 - Journal for Clinical Studies

Current Edition

Europe

Early findings from a phase 3 clinical trial report promising results

The interim results from a phase 3 clinical trial testing DCVax®-L, a dendritic cell treatment, show increased overall survival for patients with glioblastoma. Dendri...

31 May 2018 Europe 3 | clinical

Continue Reading →

Europe

Redx Pharma up as it confirms cancer drug clinical trial will re-start early next year

Redx is developing a new generation of cancer drug called a porcupine inhibitor After discussions with the re...

31 May 2018 Europe cancer | clinical

Continue Reading →

Europe

Trump signs Right to Try Act for terminally ill patients

Nine-year-old Jordan McLinn, who has muscular dystrophy, shook Mr Trump's hand President Donald Trump has sig...

31 May 2018 Europe | North America act | ill

Continue Reading →

Asia Pacific

India’s drug regulator expects to finalize new clinical trial rules in two months

India’s drug regulator plans to finalize new rules for clinical trials in a couple of months that would shorten the review time, a senior official said on Wednesday, ...

31 May 2018 Asia Pacific | Europe clinical | drug

Continue Reading →

Europe

Real-world evidence shows clinically meaningful weight loss in people receiving Saxenda®

People treated with Saxenda® (liraglutide 3 mg) for weight management lost an average of 8.1 kg after six months in a real-world clinical setting, in combination with...

31 May 2018 Europe evidence | loss

Continue Reading →

Europe

Ultragenyx and Kyowa Kirin Announce Publication of Phase 2 Study Results Demonstrating that Crysvita® (burosumab) Improved Outcomes in Children with X-linked Hypophosphatemia in the New England Journal of Medicine

Pediatric Study Demonstrated Improvements in Rickets Severity, Growth, Pain and Physical Activity in Children with Debilitating, Lifelong Hereditary Disease Ultrageny...

31 May 2018 Europe Kirin | Kyowa

Continue Reading →

Europe

SOTIO Starts Phase I/II Trial of DCVAC in Combination with ONCOS-102: The Targovax Adenovirus Based Immunotherapy

SOTIO, a biotechnology company owned by the PPF Group, announces today that the first patient was enrolled to the SP015 clinical trial of a combination of DCVAC/PCa, ...

31 May 2018 Europe DCVAC | ONCOS-10

Continue Reading →

Europe

Genmab Announces Topline Results in Phase III study of Arzerra® in Indolent Non-Hodgkin’s Lymphoma

Topline results from Phase III study in iNHL did not meet primary endpoint of improved progression-free survival Genmab A/S (Nasdaq Copenhagen: GEN) announced today ...

31 May 2018 Europe Arzerra | Genmab

Continue Reading →

Europe

Clinical Innovation Partnerships 2018

When: 03 - 04 July, 2018 Where: Radisson Blu Hotel, Zurich Airport The only event for senior Clinical Operations and Procurement professionals driving innovation in ...

23 May 2018 Europe 2018 | clinical

Continue Reading →

Australasia

Bionomics begins phase II clinical trial of drug for treating agitation

No approved treatments currently available for agitation Bionomics will recruit about 40 elderly patients in ...

23 May 2018 Australasia | Europe agitation | Bionomics

Continue Reading →